Home › NDC Lookup › RxCUI directory › RxCUI 882548

Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel — RxCUI 882548

RxNorm drug concept · Semantic clinical drug
RxCUI 882548 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI882548
Official nameClindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asclindamycin phosphate 1.2 % (clindamycin 1 % ) / tretinoin 0.025 % Topical Gel; clindamycin phosphate 1.2 % / tretinoin 0.025 % Topical Gel
FDA products mapped5
Package NDCs mapped10
Reported Medicaid activity (SDUD)3,090 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tretinoin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Honestly, it won't erase wrinkles — and the label is pretty direct about that. What it's approved to do is help reduce the appearance of fine wrinkles as part of a full routine tha...
  • Will tretinoin actually get rid of my wrinkles?
  • Redness, peeling, and irritation in the first couple of weeks are very common and usually mean your skin is adjusting — not that something is wrong. If it's tolerable, try hanging...
  • My skin is really red and peeling after the first week — should I stop?
📖 Read our full Tretinoin guide →

🕸️ Concept Web — How Clindamycin phosphate 0.012 MG/MG / tretinoin 0.... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel RxCUI 882548

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Clindamycin 2582
    • Tretinoin 10753
    • Clindamycin / tretinoin 687144
    • Clindamycin phosphate 797272
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Veltin 999924
    • Ziana 669774
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clindamycin / tretinoin Topical Gel 668329
    • Clindamycin phosphate / tretinoin Topical Gel 2647835
    • Clindamycin / tretinoin Topical Product 1152781
    • Clindamycin phosphate / tretinoin Topical Product 2659636
    • Clindamycin / tretinoin Topical Gel [Veltin] 999926
    • Clindamycin / tretinoin Topical Gel [Ziana] 672530
    • Clindamycin phosphate / tretinoin Topical Gel [Veltin] 2658841
    • Clindamycin phosphate / tretinoin Topical Gel [Ziana] 2655048
    • +4 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Clindamycin phosphate 0.012 MG/MG 882547
    • Tretinoin 0.00025 MG/MG 340005
    • Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel [Veltin] 999927
    • Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel [Ziana] 882550
    • Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG [Veltin] 999925
    • Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG [Ziana] 882549

Showing up to 8 concepts per family — 20 of 24 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clindamycin phosphate 0.012 MG/MG SCDC · 882547
  • Tretinoin 0.00025 MG/MG SCDC · 340005
  • Clindamycin / tretinoin Topical Gel SCDF · 668329
  • Clindamycin phosphate / tretinoin Topical Gel SCDFP · 2647835
  • Clindamycin / tretinoin Topical Product SCDG · 1152781
  • Clindamycin phosphate / tretinoin Topical Product SCDGP · 2659636

Brand-Name Concepts

  • Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel [Ziana] SBD · 882550
  • Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel [Veltin] SBD · 999927
  • Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG [Veltin] SBDC · 999925
  • Clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG [Ziana] SBDC · 882549
  • Clindamycin / tretinoin Topical Gel [Veltin] SBDF · 999926
  • Clindamycin / tretinoin Topical Gel [Ziana] SBDF · 672530
  • Clindamycin phosphate / tretinoin Topical Gel [Veltin] SBDFP · 2658841
  • Clindamycin phosphate / tretinoin Topical Gel [Ziana] SBDFP · 2655048
  • Veltin Topical Product SBDG · 1187763
  • Ziana Topical Product SBDG · 1187457

📦 FDA Products & Package NDCs

5 products · 10 package NDCs
10 package NDCs map to RxCUI 882548 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00472-1790-30 1 TUBE in 1 CARTON (0472-1790-30) / 30 g in 1 TUBE Clindamycin Phosphate and Tretinoin Actavis Pharma, Inc. 2016-07-05
00472-1790-60 1 TUBE in 1 CARTON (0472-1790-60) / 60 g in 1 TUBE Clindamycin Phosphate and Tretinoin Actavis Pharma, Inc. 2016-07-05
21922-0050-05 1 TUBE in 1 CARTON (21922-050-05) / 30 g in 1 TUBE Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025% Encube Ethicals, Inc. 2023-09-04
21922-0050-07 1 TUBE in 1 CARTON (21922-050-07) / 60 g in 1 TUBE Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025% Encube Ethicals, Inc. 2023-09-04
68682-0300-30 1 TUBE in 1 CARTON (68682-300-30) / 30 g in 1 TUBE Clindamycin Phosphate 1.2% and Tretinoin 0.025% Oceanside Pharmaceuticals 2020-08-04
68682-0300-60 1 TUBE in 1 CARTON (68682-300-60) / 60 g in 1 TUBE Clindamycin Phosphate 1.2% and Tretinoin 0.025% Oceanside Pharmaceuticals 2020-08-04
73473-0306-30 1 TUBE in 1 CARTON (73473-306-30) / 30 g in 1 TUBE Clindamycin Phosphate and Tretinoin Solaris Pharma Corporation 2025-01-03
73473-0306-60 1 TUBE in 1 CARTON (73473-306-60) / 60 g in 1 TUBE Clindamycin Phosphate and Tretinoin Solaris Pharma Corporation 2025-01-03
99207-0300-30 1 TUBE in 1 CARTON (99207-300-30) / 30 g in 1 TUBE ZIANA Bausch Health US, LLC 2006-12-01
99207-0300-60 1 TUBE in 1 CARTON (99207-300-60) / 60 g in 1 TUBE ZIANA Bausch Health US, LLC 2006-12-01
Observed labelers: Actavis Pharma, Inc. (2) · Bausch Health US, LLC (2) · Encube Ethicals, Inc. (2) · Oceanside Pharmaceuticals (2) · Solaris Pharma Corporation (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.